Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PHARMOBEDIENT

  • FDA Approval
  • Oct. 28, 2025, 08:51 UTC
  • 39
  • 0 comments

FDA approve QUINAPRIL HYDROCHLORIDE

Comment Full text

COVIS

  • FDA Approval
  • Oct. 28, 2025, 04:11 UTC
  • 42
  • 0 comments

FDA approve FERUMOXYTOL

Comment Full text

STERINOVA INC

  • FDA Approval
  • Oct. 27, 2025, 18:20 UTC
  • 46
  • 0 comments

FDA approve ROCURONIUM BROMIDE

Comment Full text

BAYER HEALTHCARE PHARMS

  • FDA Approval
  • Oct. 27, 2025, 17:05 UTC
  • 35
  • 0 comments

FDA approve ELINZANETANT

Comment Full text

CAPLIN

  • FDA Approval
  • Oct. 27, 2025, 09:32 UTC
  • 39
  • 0 comments

FDA approve NICARDIPINE HYDROCHLORIDE

Comment Full text

NOVITIUM PHARMA

  • FDA Approval
  • Oct. 27, 2025, 09:32 UTC
  • 45
  • 0 comments

FDA approve LOFEXIDINE HYDROCHLORIDE

Comment Full text

SAGENT PHARMS INC

  • FDA Approval
  • Oct. 27, 2025, 09:32 UTC
  • 46
  • 0 comments

FDA approve ESMOLOL HYDROCHLORIDE

Comment Full text

L PERRIGO CO

  • FDA Approval
  • Oct. 27, 2025, 09:32 UTC
  • 41
  • 0 comments

FDA approve ACETAMINOPHEN; IBUPROFEN

Comment Full text

NOVAST LABS

  • FDA Approval
  • Oct. 27, 2025, 09:32 UTC
  • 42
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

QUAGEN

  • FDA Approval
  • Oct. 27, 2025, 09:32 UTC
  • 39
  • 0 comments

FDA approve ARIPIPRAZOLE

Comment Full text
  • Previous
  • 68
  • 69
  • 70
  • 71
  • 72
  • Next

Search

News categories

  • Technical Exchange News(12129)
  • Event(5779)
  • SEC News(257764)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(152330)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin